Cancer stem cells—origins and biomarkers: perspectives for targeted personalized therapies

L Walcher, AK Kistenmacher, H Suo, R Kitte… - Frontiers in …, 2020 - frontiersin.org
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …

[HTML][HTML] Circular RNAs in cancer

DH Bach, SK Lee, AK Sood - Molecular Therapy-Nucleic Acids, 2019 - cell.com
Circular RNAs (circRNAs) are a class of single-stranded closed RNA molecules that are
formed by precursor mRNA back-splicing or skipping events of thousands of genes in …

CircRNAs and cancer: biomarkers and master regulators

E Arnaiz, C Sole, L Manterola, L Iparraguirre… - Seminars in cancer …, 2019 - Elsevier
Circular RNAs (circRNAs) are a novel class of regulatory RNAs that despite being relatively
abundant have only recently begun to be explored. There are many thousands of genes that …

Function and clinical significance of circRNAs in solid tumors

Y Geng, J Jiang, C Wu - Journal of hematology & oncology, 2018 - Springer
Circular RNA (circRNA) is a new type of endogenous non-coding RNAs (ncRNAs). circRNA
regulates gene expression in many biological processes, and it also participates in the …

Circular RNAs in hepatocellular carcinoma: biomarkers, functions and mechanisms

L Qiu, H Xu, M Ji, D Shang, Z Lu, Y Wu, Z Tu, H Liu - Life sciences, 2019 - Elsevier
Hepatocellular carcinoma (HCC), a leading cause of cancer-related death with high invasive
and metastatic potential, has a low survival rate. To improve the survival and quality of life in …

The emerging role of circRNAs and their clinical significance in human cancers

L Qian, S Yu, Z Chen, Z Meng, S Huang… - Biochimica et Biophysica …, 2018 - Elsevier
Circular RNA (circRNA), a recently discovered subclass of non-coding RNAs (ncRNAs),
forms a covalently closed loop with neither a 5′ cap structure nor a 3′ polyadenylated tail …

[HTML][HTML] Engineering polymer nanoparticles using cell membrane coating technology and their application in cancer treatments: Opportunities and challenges

K Guo, N Xiao, Y Liu, Z Wang, J Tóth, J Gyenis… - Nano Materials …, 2022 - Elsevier
Nanotechnology has revolutionized cancer drug delivery, and recent research continues to
focus on the development of “one-size-fits-all,” ie,“all-in-one” delivery nanovehicles …

Cancer stem cells in hepatocellular carcinoma: intrinsic and extrinsic molecular mechanisms in stemness regulation

X Fang, Q Yan, S Liu, XY Guan - International journal of molecular …, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) remains the most predominant type of liver cancer with an
extremely poor prognosis due to its late diagnosis and high recurrence rate. One of the …

[PDF][PDF] CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer

N Liu, J Zhang, LY Zhang… - Eur Rev Med Pharmacol …, 2018 - europeanreview.org
OBJECTIVE: CircRNAs have been recently identified as important regulators in tumors
biological functions. However, the clinical significance of circHIPK3 in epithelial ovarian …

[HTML][HTML] TV-circRGPD6 nanoparticle suppresses breast cancer stem cell-mediated metastasis via the miR-26b/YAF2 axis

X Lin, W Chen, F Wei, X Xie - Molecular Therapy, 2021 - cell.com
Metastatic tumor is a major contributor to death caused by breast cancer. However, effective
and targeted therapy for metastatic breast cancer remains to be developed. Initially, we …